Role of pentoxifylline in treatment of anemic patients suffering chronic hemodialysis: a randomized clinical trial.

Medicinski arhiv

Volumn 66, Issue 2, 2012, Pages 84-86

  Mortazavi, Mojgan ^a   Seyrafian, Shiva ^b   Taheri, Shahram ^b   Nasiri, Rezvan ^b   Dolatkhah, Shahaboddin ^b   Naini, Afsoon Emami ^b   Atapour, Abolamir ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; SERUM ALBUMIN;

ANEMIA; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84860590422     PISSN: 0350199X     EISSN: None     Source Type: Journal    
DOI: 10.5455/medarh.2012.66.84-86     Document Type: Article

References (0)